GENE ONLINE|News &
Opinion
Blog

CRISPR
Vertex Signs $700 Million worth CRISPR Pact with Jennifer Doudna Co-founded Gene Editing Firm
2021-10-26
Intellia’s CRISPR Drug Claims FDA Orphan Drug Designation to Treat ATTR Amyloidosis
2021-10-22
Landmark CRISPR Trial Shows Promise Against Fighting Blindness, but Is It a Cure?
2021-10-08
MD Anderson to Develop Microbiome Cancer Therapeutics with CRISPR Gene-Editing
2021-09-14
Jennifer Doudna’s Gene Editing Firm Mammoth Biosciences Attains Unicorn Status
2021-09-11
Feng Zhang’s Team Engineer “Ultra-Compact” Cas-13 To Solve Packaging and Delivery Issues of RNA Editors
2021-09-05
Years After Playing Second Fiddle to CRISPR, RNA Editing Comes Into Its Own – An Interview with Dr. Joshua Rosenthal
2021-08-25
Vertex Inks $1.2B Pact with Feng Zhang Cofounded Startup to Develop Gene Therapies for Blood Diseases
2021-08-25
New Era in Precision Medicine? Introduction & Overview of RNA Editing
2021-08-23
This CRISPR-Based Test Can Detect COVID-19 Variants From Your Spit
2021-08-13
Game-Changer in Malaria Prevention: CRISPR-Based Genetic Engineering May Eradicate Malaria Vector Anopheles
2021-08-02
Germline Editing in Marsupials Marks Another Milestone for CRISPR
2021-08-01
Reprogrammed CRISPR Tool Could Target Emerging SARS-CoV-2 Variants
2021-07-28
Primed to Surpass CRISPR: Prime Medicine Emerges Out of Stealth with $315 Million in Funding
2021-07-15
A New Era Begins! Intellia Reports First Clinical Proof for Direct CRISPR Genome Editing in Humans
2021-06-27
1 2 3 4 7
LATEST
AstraZeneca Welcomes Neurofibromatosis And Asthma Treatment Approvals in Japan
2022-09-28
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
Sciwind Biosciences And SynerK Join Forces To Develop siRNA Therapeutics
2022-09-27
Acticor Enrolls First Patient in Phase 2/3 Stroke Treatment Study
2022-09-27
Daiichi Sankyo Wins Approval For Cancer Treatment in Japan
2022-09-26
Seagen Strikes Potential $650 million Deal with LAVA Therapeutics for Cancer Treatment
2022-09-26
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!